Samil Pharmaceutical Co.,Ltd (000520.KS)

KRW 13130.0

(-3.95%)

Long Term Debt Summary of Samil Pharmaceutical Co.,Ltd

  • Samil Pharmaceutical Co.,Ltd's latest annual long term debt in 2023 was 49.56 Billion KRW , down -32.38% from previous year.
  • Samil Pharmaceutical Co.,Ltd's latest quarterly long term debt in 2024 Q2 was 65.83 Billion KRW , down -14.56% from previous quarter.
  • Samil Pharmaceutical Co.,Ltd reported annual long term debt of 73.3 Billion KRW in 2022, up 122.72% from previous year.
  • Samil Pharmaceutical Co.,Ltd reported annual long term debt of 32.91 Billion KRW in 2021, up 62.08% from previous year.
  • Samil Pharmaceutical Co.,Ltd reported quarterly long term debt of 77.04 Billion KRW for 2024 Q1, up 55.43% from previous quarter.
  • Samil Pharmaceutical Co.,Ltd reported quarterly long term debt of 49.56 Billion KRW for 2023 FY, down -32.38% from previous quarter.

Annual Long Term Debt Chart of Samil Pharmaceutical Co.,Ltd (2023 - 2007)

Historical Annual Long Term Debt of Samil Pharmaceutical Co.,Ltd (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 49.56 Billion KRW -32.38%
2022 73.3 Billion KRW 122.72%
2021 32.91 Billion KRW 62.08%
2020 20.3 Billion KRW -55.15%
2019 45.28 Billion KRW 0.0%
2018 - KRW -100.0%
2017 27 Billion KRW 1250.0%
2016 2 Billion KRW 0.0%
2015 - KRW -100.0%
2014 8 Billion KRW 0.0%
2013 - KRW -100.0%
2012 7 Billion KRW 0.0%
2011 - KRW -100.0%
2010 10 Billion KRW 20.63%
2009 8.29 Billion KRW -47.76%
2008 15.87 Billion KRW 0.0%
2007 - KRW 0.0%

Peer Long Term Debt Comparison of Samil Pharmaceutical Co.,Ltd

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW -263.404%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 75.469%
Ildong Holdings Co., Ltd. 29.87 Billion KRW -65.91%
HANDOK Inc. 123.78 Billion KRW 59.954%
Kukje Pharma Co., Ltd. 475.74 Million KRW -10319.172%
Yuhan Corporation 60.23 Billion KRW 17.707%
Dong-A ST Co., Ltd. 161.99 Billion KRW 69.401%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -48583.499%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW 39.572%
Hanall Biopharma Co.,Ltd 590.3 Million KRW -8297.034%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -719.313%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW -167.613%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW -293.894%
Hana Pharm Co., Ltd. 1.59 Billion KRW -3000.265%
Yuyu Pharma, Inc. 13.64 Billion KRW -263.404%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -41318.052%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW 59.034%
Aprogen pharmaceuticals,Inc. 32 Billion KRW -54.901%
JW Holdings Corporation 20.65 Billion KRW -139.956%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW -234.353%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW -65.228%
JW Pharmaceutical Corporation 30 Billion KRW -65.228%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -22538.033%
Hyundai Pharmaceutical Co., Ltd. 580.64 Million KRW -8436.777%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW -1013.397%
Yuyu Pharma, Inc. 13.64 Billion KRW -263.404%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW -160.507%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW 46.938%
JW Pharmaceutical Corporation 30 Billion KRW -65.228%
Yuhan Corporation 60.23 Billion KRW 17.707%
Jeil Pharma Holdings Inc 10.5 Billion KRW -372.081%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW -22.762%
Suheung Co., Ltd. 74 Billion KRW 33.022%
JW Pharmaceutical Corporation 30 Billion KRW -65.228%
Samjin Pharmaceuticals Co., Ltd. 4.16 Billion KRW -1089.651%
Korea United Pharm Inc. 10.96 Billion KRW -352.164%
CKD Bio Corp. 69.43 Billion KRW 28.608%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW -43.366%
Dongwha Pharm.Co.,Ltd 16.12 Billion KRW -207.35%
Whan In Pharm Co.,Ltd. 307.05 Million KRW -16043.123%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -22538.033%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW 31.262%
Boryung Corporation 151.7 Billion KRW 67.326%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW 36.876%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -719.313%
JW Lifescience Corporation 168 Million KRW -29405.037%